ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer: combo therapy aims to shrink tumors
Disease control Recruiting nowThis study tests a new drug (RBS2418) added to a standard immunotherapy combination (tremelimumab plus durvalumab) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the new combo helps control the cancer longer and shrinks tumors. Abou…
Matched conditions: ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 26, 2026 11:07 UTC
-
New hope for liver cancer: experimental combo enters human testing
Disease control Recruiting nowThis early-stage trial tests a new drug (SHR-2524) combined with bevacizumab in 36 adults with advanced liver cancer that cannot be removed by surgery. Participants have not had prior cancer treatment. The study focuses on safety and how the drugs move through the body, not on cu…
Matched conditions: ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:03 UTC